Ad
related to: small interfering rna
Search results
Novartis (NVS) Announces Positive Long-Term Data on Leqvio
Zacks via Yahoo Finance· 9 months agoNovartis NVS announced new long-term data on the cholesterol-lowering drug Leqvio at the European...
10 clinical trials to watch in the first half of 2024
BioPharma Dive via Yahoo Finance· 5 months agoTwo years into a drawn-out downturn, the biotechnology sector finally got news that might buoy its...
One dose of experimental therapy reduced lipoprotein(a) more than 94% for nearly a year
NewMediaWire via Yahoo Finance· 7 months agoResearch Highlights: In this first trial in people, a single dose of a new therapeutic called...
Alys launches with $100M and a pipeline of skin disease drugs
BioPharma Dive via Yahoo Finance· 4 months agoEuropean venture firm Medicxi built the startup by combining six of its portfolio companies, similar...
Alnylam's Strategy Is Getting Bigger. Time to Buy?
Motley Fool· 2 years agoAfter earning its fifth new drug approval in four short years, you might expect Alnylam (NASDAQ: ALNY) to take a moment to rest on its laurels. Those of you who know the company a little better ...
Comanche Biopharma raises $75M to fund preeclampsia drug testing
BioPharma Dive via Yahoo Finance· 5 months agoThe biotech is developing an RNA-based therapy for what it describes as a root cause of the...
Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoAmgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript May 2, 2024 Amgen Inc. beats earnings...
Novo Nordisk A/S (NYSE:NVO) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoNovo Nordisk A/S (NYSE:NVO) Q4 2022 Earnings Call Transcript February 1, 2023 Operator: Good day,...
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
Motley Fool· 1 year agoInvestors were optimistic on Wednesday, sending the Nasdaq Composite (NASDAQINDEX: ^IXIC) up a third...
7 A-Rated Biotech Stocks for Your August Buy List
InvestorPlace via Yahoo Finance· 10 months agoBiotech stocks aren’t for everyone. But if you want to dive into a sector that can potentially give you incredible returns, you’ll want to focus your...
